bioRxiv Science⌕ Search

Biology subjects

Fatumo, S.

Publications and source records attributed to Fatumo, S..

8 recordsLinked to original sources

Trustworthy agentic genomics through versioned skill libraries

Genomics is adopting autonomous AI agents that interpret genomes from natural-language instructions faster than it is building the means to trust them. We report the first large-scale controlled evaluation of where, in an agentic genomic pipeline, correctness must reside for the system to be trustworthy at clinical scale. Using pharmacogenomics, a domain where errors are measurable and sometimes lethal, we benchmarked nine frontier large language models across 44,550 scored evaluations on 110 pharmacogenomic cases, and tested model interpretation of real star-allele diplotypes from more than 7,000 individuals in three ancestrally diverse populations. Trustworthiness proved to be a property of pipeline architecture, not of the model. Letting the model reason was stochastic and unsafe, and grounding it in the correct guidelines by retrieval paradoxically increased lethal-class errors. Encoding the validated decision logic as a versioned skill and executing it as code made the pharmacogenomic mapping exact, auditable and identical across models, confining all residual error to a single input-interpretation step. On individual genomes, unguarded model interpretation degraded along an ancestry gradient; execution removes this gradient from the clinical mapping, relocating it to the auditable completeness of the input caller. This establishes a generalisable, auditable architecture for trustworthy agentic genome interpretation at scale. HighlightsO_LICorrectness must be executed, not reasoned or retrieved, to be trustworthy C_LIO_LIRetrieval raises phenotype accuracy yet increases lethal-class errors; skills do not C_LIO_LIExecution makes the clinical mapping exact and model-invariant; error stays at input C_LIO_LIA deterministic input caller is the predicted route to all-correct emitted answers C_LI In briefCorpas and colleagues show that trustworthy agentic genome interpretation comes not from making language models reason correctly about biology, but from confining them to interpreting input while versioned, validated skills do the reasoning as executed code. Across nine large language models and 110 pharmacogenomics cases, executing the skill makes the clinical mapping deterministic, auditable and model-invariant. SignificanceGenomics is adopting autonomous, language-model-mediated agents faster than it is building the standards needed to trust them. On a pharmacogenomic benchmark with lethal-class consequences, we show that an agents trustworthiness is not a property of the model but of how the agent is constrained: correctness must be moved out of the stochastic model into a versioned skill executed as code, with the model confined to interpreting heterogeneous input. This gives the field a transferable architecture for trustworthy agentic genome interpretation, a predicted route to deploying it so that every emitted answer is correct (execute the validated skill, call the input deterministically, and abstain on the irreducible residual), and a way to develop genomic skills as validated, executable, versioned units rather than prompts. Following a validation framework described elsewhere, we use clinical-grade to mean determinism, auditability, traceability to versioned components and population-invariant performance, all achieved under skill-constrained execution. We distinguish two senses of population performance: the executed clinical mapping is population-invariant by construction, verified across European, Latin American and East African origin individuals, whereas the models interpretation of real, ancestrally diverse diplotypes is not, degrading along an ancestry gradient, which is precisely why the mapping must be executed rather than reasoned. We do not claim full clinical validation, which would additionally require non-canonical inputs, real-world genomic and clinical data, human comparators and multi-site concordance.

genomics↗

Multi-ancestry fine-mapping accounting for ancestral and environmental heterogeneity improves resolution and interpretation

Amongst genome-wide association studies (GWAS) across diverse populations, allelic effect heterogeneity may arise due to differences in genetic ancestry and environmental exposures. This heterogeneity impacts the refinement of sets of potential causal variants underlying genetic associations through statistical fine-mapping. We introduce two multi-ancestry fine-mapping methods, MR-MEGAfm and env-MR-MEGAfm, allowing for multiple causal variants in a genomic region. Both methods integrate GWAS summary statistics and differing linkage disequilibrium from multiple cohorts; env-MR-MEGAfm additionally incorporates summary-level environmental covariates. Through simulations, we show that, when allelic heterogeneity is correlated with environmental exposures and ancestry, env-MR-MEGAfm yields improved resolution over MR-MEGAfm and similar resolution to SuSiEx. In twelve sex-stratified African GWAS of low-density lipoprotein cholesterol in 19,589 individuals, MR-MEGAfm and env-MR-MEGAFM (adjusting for urban status) identify five variants with posterior probability > 0.5 within two loci. One variant showed heterogeneity only due to ancestry, while three showed heterogeneity due only to urban status.

genetics↗

Accounting for heterogeneity due to environmental sources in meta-analysis of genome-wide association studies

Meta-analysis of genome-wide association studies (GWAS) across diverse populations offers power gains to identify loci associated with complex traits and diseases. Often heterogeneity in effect sizes across populations will be correlated with genetic ancestry and environmental exposures (e.g. lifestyle factors). We present an environment-adjusted meta-regression model (env-MR-MEGA) to detect genetic associations by adjusting for and quantifying environmental and ancestral heterogeneity between populations. In simulations, env-MR-MEGA had similar or greater association power than MR-MEGA, with notable gains when the environmental factor had a greater correlation with the trait than ancestry. In our analysis of low-density lipoprotein cholesterol in [~]19,000 individuals across twelve sex-stratified GWAS from Africa, adjusting for sex, BMI, and urban status, we identified additional heterogeneity beyond ancestral effects for nine variants. Env-MR-MEGA provides an approach to account for environmental effects using summary-level data, making it a useful tool for meta-analyses without the need to share individual-level data.

genetics↗

Leveraging information between multiple population groups and traits improves fine-mapping resolution

Statistical fine-mapping helps to pinpoint likely causal variants underlying genetic association signals. Its resolution can be improved by (i) leveraging information between traits; and (ii) exploiting differences in linkage disequilibrium structure between diverse population groups. Using association summary statistics, MGflashfm jointly fine-maps signals from multiple traits and population groups; MGfm uses an analogous framework to analyse each trait separately. We also provide a practical approach to fine-mapping with out-of-sample reference panels. In simulation studies we show that MGflashfm and MGfm are well-calibrated and that the mean proportion of causal variants with PP>0.80 is above 0.75 (MGflashfm) and 0.70 (MGfm). In our analysis of four lipids traits across five population groups, MGflashfm gives a median 99% credible set reduction of 10.5% over MGfm. MGflashfm and MGfm only require summary level data, making them very useful fine-mapping tools in consortia efforts where individual-level data cannot be shared.

genomics↗

Whole-genome sequencing across 449 samples spanning 47 ethnolinguistic groups provides insights into genetic diversity in Nigeria

African populations have been drastically underrepresented in genomics research and failure to capture the genetic diversity across the numerous ethnolinguistic groups (ELGs) found in the continent has hindered the equity of precision medicine initiatives globally. Here, we describe the whole-genome sequencing of 449 Nigerian individuals across 47 unique self-reported ELGs. Population structure analysis reveals genetic differentiation amongst our ELGs, consistent with previous findings. From the 36 million SNPs and INDELs discovered in our dataset, we provide a high-level catalog of both novel and medically-relevant variation present across the ELGs. These results emphasize the value of this resource for genomics research, with added granularity by representing multiple ELGs from Nigeria. Our results also underscore the potential of using these cohorts with larger sample sizes to improve our understanding of human ancestry and health in Africa.

genomics↗

SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody

BackgroundSARS-CoV-2, the causative virus for COVID-19 has now super-mutated into the Omicron (Om) variant. On its spike glycoprotein alone, more than 30 substitutions have been characterized with 15 within the receptor binding domain (RBD); It therefore calls to question the transmissibility and antibody escapability of Omicron. This study was setup to investigate the Omicron RBDs interaction with ACE2 (host receptor) and a SARS-CoV-2 neutralizing monoclonal antibody (mAb). MethodsIn-silico mutagenesis was used to generate the Om-RBD in complex with ACE2 or mAb from the wildtype. All-atom molecular dynamics (MD) simulation trajectories were analyzed for interaction. ResultsMD trajectories showed that Omicron RBD has evolved into an efficient ACE2 binder, via pi-pi (Om-RBD-Y501/ACE2-Y41) and salt-bridge (Om-RBD-K493/ACE2-Y41) interactions. Conversely, in binding mAb, it has become less efficient (Center of mass distance of RBD from mAb complex, wildtype {approx} 30 [A], Omicron {approx} 41 [A]). Disruption of Om-RBD/mAb complex resulted from loose interaction between Om-RBD and the light chain complementarity-determining region residues. ConclusionsOmicron is expected to be better transmissible and less efficiently interacting with neutralizing convalescent mAbs. General significanceOur results elucidate the mechanisms for higher transmissibility in Omicron variant.

bioinformatics↗

Polygenic Prediction of Type 2 Diabetes in Continental Africa

ObjectivePolygenic prediction of type 2 diabetes in continental Africans is adversely affected by the limited number of genome-wide association studies (GWAS) of type 2 diabetes from Africa, and the poor transferability of European derived polygenic risk scores (PRS) in diverse ethnicities. We set out to evaluate if African American or multi-ethnic derived PRSs would improve polygenic prediction in continental Africans. Research Design and MethodsUsing the PRSice software, ethnic-specific PRSs were computed with weights from the type 2 diabetes GWAS of the Million Veteran Program (MVP) study. The South African Zulu study (1602 cases and 976 controls) was used as the target data set. Replication and assessment of the best predictive PRS association with age at diagnosis was done in the Africa America Diabetes Mellitus (AADM) study (1031 cases and 738 controls). ResultsThe African American derived PRS was more predictive of type 2 diabetes compared to the European and multi-ethnic derived scores. Notably, participants in the 10th decile of this PRS had a 3.19-fold greater risk (OR 3.19; 95%CI (1.94-5.29), p = 5.33 x10-6) of developing diabetes and were diagnosed 2.6 years earlier compared to those in the first decile. ConclusionsAfrican American derived PRS enhances polygenic prediction of type 2 diabetes in continental Africans. Improved representation of non-Europeans populations (including Africans) in GWAS, promises to provide better tools for precision medicine interventions in type 2 diabetes.

genetics↗

Discovery and fine-mapping of kidney function loci in first genome-wide association study in Africans

Genome-wide association studies (GWAS) for kidney function have uncovered hundreds of risk loci, primarily in populations of European ancestry. We conducted the first GWAS of estimated glomerular filtration rate (eGFR) in Africa in 3288 Ugandans and replicated the findings in 8224 African Americans. We identified two loci associated with eGFR at genome-wide significance (p<5x10-8). The most significantly associated variant (rs2433603, p=2.4x10-9) in GATM was distinct from previously reported signals. A second association signal mapping near HBB (rs141845179, p=3.0x10-8) was not significant after conditioning on a previously reported SNP (rs334) for eGFR. However, fine-mapping analyses highlighted rs141845179 to be the most likely causal variant at the HBB locus (posterior probability of 0.61). A trans-ethnic GRS of eGFR constructed from previously reported lead SNPs was not predictive into the Ugandan population, indicating that additional large-scale efforts in Africa are necessary to gain further insight into the genetic architecture of kidney disease.

genetics↗